Inovio Pharmaceuticals, Inc. (INO) quarterly cash flow statement — complete operating, investing & financing history
Inovio Pharmaceuticals, Inc. (INO) cash flow statement — 27-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -18.05M | -21.59M | -19.37M | -21.57M | -20.81M | -26.87M | -19.66M | -27.44M | -28.21M | -28.76M | -26.28M | -29.11M | -32.31M | -36.66M | -36.34M | -67.47M | -50.53M | -61.88M | -37.89M | -46.49M |
| Operating CF Margin % | - | - | - | - | - | -41127.63% | -16807.62% | - | -27996.02% | - | -25597.2% | -7494.13% | -14300.36% | -31897.97% | -29149.91% | -736.99% | -6441.65% | -31084.97% | -4515.61% | -15937.96% |
| Operating CF Growth % | 13.28% | 19.66% | 1.49% | 21.39% | 26.23% | 6.56% | 25.16% | 5.73% | 12.7% | 21.56% | 27.69% | 56.85% | 36.05% | 40.75% | 4.09% | -45.12% | 35.6% | -17.05% | 26.02% | 37.31% |
| Net Income | -6.01M | -19.68M | 3.76M | -45.5M | -23.52M | -19.69M | -19.38M | -25.17M | -32.24M | -30.47M | -25M | -33.93M | -35.53M | -40.65M | -54.46M | -37.78M | -108.5M | -79.07M | -106.95M | -60.17M |
| Depreciation & Amortization | 765.89K | 745.46K | 754.05K | 749.66K | 741.67K | 743.45K | 775.83K | 765.86K | 828.63K | 759.73K | 175.23K | 1.03M | 1.14M | 1.15M | 1.35M | 1.36M | 1.41M | 1.38M | 2.24M | 1.16M |
| Stock-Based Compensation | 0 | 698.74K | 764.56K | 757.09K | 834.79K | 1.4M | 1.32M | 1.24M | 1.51M | 2.53M | 2.27M | 2.08M | 2.92M | 3.81M | 3.27M | 3.23M | 8.34M | 7.71M | 5.47M | 5.62M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -32.05K | 0 | 1.09M | 0 | 4.03M | 0 | 0 | 0 | 2.64M | 0 |
| Other Non-Cash Items | -12.63M | -1.84M | -20.85M | 23.15M | 1.04M | -4.55M | -1.64M | -1.42M | -91.74K | -724K | -1.57M | 9.09M | 313.49K | -2.45M | -3.44M | 2.35M | 5.02M | 7.76M | -382.75K | 1.61M |
| Working Capital Changes | -171.67K | -1.51M | -3.81M | -730.43K | 94.36K | -4.77M | -731.05K | -2.86M | 1.78M | -851.25K | -2.11M | -7.38M | -2.24M | 1.48M | 12.91M | -36.63M | 43.21M | 344.2K | 59.08M | 5.3M |
| Change in Receivables | 0 | 0 | 0 | -138.28K | 469.93K | -111.18K | 663.68K | -89.07K | 777.42K | -145.85K | -261.03K | 2.97M | -81.12K | 6.7M | -1.66M | 1.29M | -3.88M | 541.25K | -906.96K | 6.73M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.77M | 0 | 0 | 0 | 0 | 0 | 41.78M | 0 |
| Change in Payables | 2.39M | -1.86M | -4.58M | -350.13K | 2.66M | -4.16M | 973.72K | -1.98M | 798.19K | -3.16M | 4.65M | -6.69M | -3.22M | -40.74M | 5.28M | -30.77M | 67.09M | -9M | 18.87M | -2.75M |
| Cash from Investing | 6.15M | 2.64M | -58.19K | 8.87M | 5.28M | -51.75K | 34.64M | 14.08M | 9.97M | 45.38M | 19.94M | -5.49M | 53.91M | 19M | 54M | 44.56M | -10.3M | 21.33M | -6.49M | 55.96M |
| Capital Expenditures | 0 | 0 | -127.44K | -67.95K | -30.93K | -59.37K | 0 | 0 | -452.25K | -35.58K | 320.9K | 0 | -23.91K | -296.98K | -165.11K | -86.83K | -717.21K | 2M | -643.66K | -168.61K |
| CapEx % of Revenue | - | - | - | - | - | 90.86% | 0% | - | 448.83% | - | 312.61% | - | 10.58% | 258.37% | 132.44% | 0.95% | 91.44% | 1004.65% | 76.71% | 57.8% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 59.32K | 0 | 0 | 0 | 0 | 0 | -53.93M | 0 | 2M | -44.64M | 9.59M | -2M | 1.44T | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -172.63K | 0 | 53.93M | 6.07M | -2M | 44.64M | -9.59M | -2M | -1.44T | 0 |
| Cash from Financing | 17.16M | 953.79K | 27.13M | 24.92M | -34.78K | 1.03M | 29.15M | 660.65K | 33.03M | -11.36M | 1.84M | 698.63K | 2.88M | -424.7K | 6.67M | 3.81M | 42.94M | 28.42M | 47.59M | -440.78K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 17.21M | 1.08M | 27.13M | 24.92M | 0 | 1.1M | 29.15M | 667.07K | 17.06M | 5.23M | 1.84M | 708.28K | 2.92M | 0 | 6.67M | 3.77M | 43.16M | 29.36M | 47.34M | 255.41K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -55.96K | -130.24K | 0 | -1.79K | -34.78K | -74.22K | 0 | -6.42K | 15.97M | -174.25K | 0 | -9.65K | -32.29K | -424.7K | 0 | 45.6K | -217.69K | -942.52K | 258.54K | -696.19K |
| Net Change in Cash | 5.25M | -18M | 7.71M | 12.22M | -15.56M | -25.9M | 44.13M | -12.7M | 14.79M | 5.29M | -4.49M | -33.91M | 24.47M | -18.09M | 24.34M | -19.11M | -17.91M | -12.13M | 3.2M | 9.02M |
| Free Cash Flow | -18.05M | -21.59M | -19.5M | -21.64M | -20.84M | -26.93M | -19.66M | -27.44M | -28.66M | -28.8M | -25.95M | -29.11M | -32.34M | -36.96M | -36.51M | -67.55M | -51.25M | -59.88M | -38.53M | -46.66M |
| FCF Margin % | - | - | - | - | - | -41218.49% | -16807.62% | - | -28444.85% | - | -25284.59% | -7494.13% | -14310.94% | -32156.34% | -29282.36% | -737.94% | -6533.08% | -30080.32% | -4592.32% | -15995.76% |
| FCF Growth % | 13.41% | 19.83% | 0.84% | 21.14% | 27.28% | 6.47% | 24.24% | 5.73% | 11.37% | 22.09% | 28.9% | 56.91% | 36.89% | 38.28% | 5.27% | -44.78% | 34.86% | -12.82% | 26.15% | 37.4% |
| FCF per Share | -0.22 | -0.31 | -0.28 | -0.41 | -0.54 | -0.70 | -0.61 | -0.98 | -1.05 | -1.24 | -1.14 | -1.30 | -1.47 | -1.72 | -1.71 | -0.27 | -0.22 | -0.27 | -0.18 | -0.22 |
| FCF Conversion (FCF/Net Income) | 3.00x | 1.10x | -5.15x | 0.47x | 0.88x | 1.36x | 1.01x | 1.09x | 0.88x | 0.94x | 1.05x | 0.86x | 0.91x | 0.90x | 0.67x | 1.79x | 0.47x | 0.78x | 0.35x | 0.77x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 533.49K | 0 | 533.49K | 0 | 533.19K | 0 | 0 | 0 | 533.49K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 66.69K | 0 | 0 | 0 | 0 | 442.98K | 0 | 0 | 0 | 0 | 0 | 465.84K | 67.64K | 533.49K | 0 | 0 |